Here are three things to know:
1. Mr. Cycyota has more than 35 years of experience in the medical device and orthobiologics industry.
2. Before he joined AlloSource, Mr. Cycyota served as the vice president of alternate care business at Johnson & Johnson Medical.
3. Under his leadership, AlloSource became one of the largest tissue banks in the country. AlloSource is the a world leader in fresh articular cartilage allografts and one of the largest providers of human allograft skin to treat severe burns in the U.S.
More articles on biologics:
1st patient enrolled in Cerapedics’ TLIF clinical trial: 5 takeaways
Who are the 10 key players in the $226B spine biologics market?
206 Ortho gets bio-inspired patent: 3 quick notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
